HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Tanaka Selected Research

N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide

12/2007Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
5/2006Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury.
7/2005Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Tanaka Research Topics

Disease

9Neoplasms (Cancer)
10/2021 - 12/2016
7Stroke (Strokes)
05/2008 - 07/2005
5Ischemic Stroke
03/2009 - 07/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 02/2021
3Inflammation (Inflammations)
01/2021 - 11/2019
3Brain Edema (Cerebral Edema)
03/2009 - 03/2007
3Brain Ischemia (Cerebral Ischemia)
05/2008 - 05/2006
3Infarction (Infarctions)
08/2007 - 07/2005
3Reperfusion Injury
05/2006 - 01/2003
2Respiratory Insufficiency (Respiratory Failure)
09/2020 - 08/2018
2Pathologic Constriction (Stenosis)
01/2020 - 01/2020
2Hematoma
11/2019 - 03/2009
2Cerebral Hemorrhage
03/2009 - 07/2005
2Thrombotic Stroke
10/2007 - 08/2007
1Liver Diseases (Liver Disease)
10/2021
1Acute fatty liver of pregnancy
10/2021
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
10/2021
1Hepatitis
10/2021
1Autoimmune Hepatitis
10/2021
1Necrosis
10/2021
1Acinar Cell Carcinoma
09/2021
1Plasma Cell Granuloma
07/2021
1Lung Neoplasms (Lung Cancer)
02/2021
1Febrile Neutropenia
01/2021
1Proteinuria
01/2021
1IGA Glomerulonephritis (IGA Nephropathy)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Infections
01/2021
1Neutropenia
01/2021
1Pneumothorax
12/2020
1Sarcoidosis (Schaumann Disease)
09/2020
1Adenocarcinoma
01/2020
1Atrophy
01/2020
1Carcinoma in Situ
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Obstructive Jaundice (Cholestatic Jaundice)
11/2019
1Cholangiocarcinoma
11/2019
1Cholestasis
11/2019
1Bird Fancier's Lung
11/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2019
1Teratoma (Teratoid Tumor)
05/2019
1Hemoptysis
08/2018
1Hemorrhage
08/2018
1Atrial Fibrillation
08/2018
1Hypoxia (Hypoxemia)
08/2018
1Margins of Excision
12/2017
1Melanoma (Melanoma, Malignant)
12/2016

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
03/2009 - 03/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021 - 07/2003
3N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamideIBA
12/2007 - 07/2005
320-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
12/2007 - 07/2005
3Dizocilpine Maleate (Dizocilpine)IBA
10/2007 - 06/2007
2Immunoglobulin G (IgG)IBA
10/2021 - 11/2019
2SteroidsIBA
01/2020 - 07/2003
2Neuroprotective AgentsIBA
08/2007 - 06/2007
2Tissue Plasminogen Activator (Alteplase)FDA Link
06/2007 - 05/2006
2PhenetidineIBA
11/2004 - 01/2003
2SEA 0400IBA
11/2004 - 01/2003
1AutoantibodiesIBA
10/2021
1Fluconazole (Zonal)FDA LinkGeneric
10/2021
1GemcitabineFDA Link
10/2021
1Conditioned Culture MediaIBA
10/2021
1diethyl maleateIBA
10/2021
1halofuginoneIBA
10/2021
1Aldehyde DehydrogenaseIBA
10/2021
1Immunoglobulins (Immunoglobulin)IBA
07/2021
1Glutamine (L-Glutamine)FDA Link
02/2021
1GlutaminaseIBA
02/2021
1atezolizumabIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1BilirubinIBA
01/2020
1Kelch-Like ECH-Associated Protein 1IBA
01/2020
1Bile Pigments (Bilin)IBA
11/2019
1EnzymesIBA
11/2019
1ImmunosorbentsIBA
11/2019
1AntibodiesIBA
11/2019
1FibrinIBA
05/2019
1ferric ferrocyanide (Prussian blue)FDA Link
08/2018
1HemosiderinIBA
08/2018
1DabigatranFDA Link
08/2018
1idarucizumabIBA
08/2018
1Hormones (Hormone)IBA
12/2017
1Microphthalmia-Associated Transcription FactorIBA
12/2016

Therapy/Procedure

4Therapeutics
02/2021 - 06/2007
2Pancreatectomy
09/2021 - 01/2020
2Hepatectomy
07/2021 - 01/2020
2Anesthesia
04/2014 - 01/2009
1Cesarean Section (Caesarean Section)
10/2021
1Drug Therapy (Chemotherapy)
10/2021
1Aftercare (After-Treatment)
01/2021
1Antibiotic Prophylaxis
01/2021
1Immunotherapy
01/2021
1Chest Tubes (Chest Tube)
12/2020
1Thoracostomy
12/2020
1Mechanical Ventilators (Ventilator)
09/2020
1Palliative Care (Palliative Therapy)
01/2020
1Endoscopic Sphincterotomy
11/2019
1Cholecystectomy
11/2019